Health-Related Quality of Life, Psychological Distress, and Sexual Changes Following Prostate Cancer: A Comparison of Gay and Bisexual Men With Heterosexual Men.

INTRODUCTION - Decrements in health-related quality of life (HRQOL) and sexual difficulties are a recognized consequence of prostate cancer (PCa) treatment. However little is known about the experience of gay and bisexual (GB) men.

AIM - HRQOL and psychosexual predictors of HRQOL were examined in GB and heterosexual men with PCa to inform targeted health information and support.

METHODS - One hundred twenty-four GB and 225 heterosexual men with PCa completed a range of validated psychosexual instruments.

MAIN OUTCOME MEASURES - Functional Assessment of Cancer Therapy - Prostate (FACT-P) was used to measure HRQOL, with validated psychosexual measures, and demographic and treatment variables used as predictors.

RESULTS - GB men were significantly younger (64. 25 years) than heterosexual men (71. 54 years), less likely to be in an ongoing relationship, and more likely to have casual sexual partners. Compared with age-matched population norms, participants in both groups reported significantly lower sexual functioning and HRQOL, increased psychological distress, disruptions to dyadic sexual communication, and lower masculine self-esteem, sexual confidence, and sexual intimacy. In comparison with heterosexual men, GB men reported significantly lower HRQOL (P = . 046), masculine self-esteem (P < . 001), and satisfaction with treatment (P = . 013); higher psychological distress (P = . 005), cancer related distress (P < . 001) and ejaculatory concern (P < . 001); and higher sexual functioning (P < . 001) and sexual confidence (P = . 001). In regression analysis, psychological distress, cancer-related distress, masculine self-esteem, and satisfaction with treatment were predictors of HRQOL for GB men (R(2)Adj = . 804); psychological distress and sexual confidence were predictors for heterosexual men (R(2)Adj = . 690).

CONCLUSIONS - These findings confirm differences between GB and heterosexual men in the impact of PCa on HRQOL across a range of domains, suggesting there is a need for GB targeted PCa information and support, to address the concerns of this "hidden population" in PCa care.

The journal of sexual medicine. 2016 Feb 04 [Epub ahead of print]

Jane M Ussher, Janette Perz, Andrew Kellett, Suzanne Chambers, David Latini, Ian D Davis, Duncan Rose, Gary W Dowsett, Scott Williams

Centre for Health Research, School of Medicine, Western Sydney University, Sydney, New South Wales, Australia. Centre for Health Research, School of Medicine, Western Sydney University, Sydney, New South Wales, Australia. , Centre for Health Research, School of Medicine, Western Sydney University, Sydney, New South Wales, Australia. , Menzies Health Institute, Griffith University, Queensland, Australia; Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP). , Baylor College of Medicine, Houston, Texas, United States. , Monash University, Melbourne, Victoria, Australia; Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP); Eastern Health, Melbourne, Victoria, Australia. , Centre for Health Research, School of Medicine, Western Sydney University, Sydney, New South Wales, Australia. , Australian Research Centre in Sex, Health and Society, La Trobe University, Melbourne, Victoria, Australia. , Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP).

PubMed

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe